Cost Effectiveness of Nivolumab in Combination with Ipilimumab for the Treatment of Advanced Melanoma Patients in England
Abstract
Authors
D Lee A Amadi J Sabater J Ellis H Johnson N Roskell Y Meng K Patterson
D Lee A Amadi J Sabater J Ellis H Johnson N Roskell Y Meng K Patterson
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now